Cargando…
A Phase 1 Randomized, Double Blind, Placebo Controlled Rectal Safety and Acceptability Study of Tenofovir 1% Gel (MTN-007)
OBJECTIVE: Rectal microbicides are needed to reduce the risk of HIV acquisition associated with unprotected receptive anal intercourse. The MTN-007 study was designed to assess the safety (general and mucosal), adherence, and acceptability of a new reduced glycerin formulation of tenofovir 1% gel. M...
Autores principales: | Mcgowan, Ian, Hoesley, Craig, Cranston, Ross D., Andrew, Philip, Janocko, Laura, Dai, James Y., Carballo-Dieguez, Alex, Ayudhya, Ratiya Kunjara Na, Piper, Jeanna, Hladik, Florian, Mayer, Ken |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616022/ https://www.ncbi.nlm.nih.gov/pubmed/23573238 http://dx.doi.org/10.1371/journal.pone.0060147 |
Ejemplares similares
-
High levels of adherence to a rectal microbicide gel and to oral Pre-Exposure Prophylaxis (PrEP) achieved in MTN-017 among men who have sex with men (MSM) and transgender women
por: Carballo-Diéguez, Alex, et al.
Publicado: (2017) -
Mucosal effects of tenofovir 1% gel
por: Hladik, Florian, et al.
Publicado: (2015) -
Rectal 1% Tenofovir Gel Use Associates with Altered Epidermal Protein Expression
por: Romas, Laura, et al.
Publicado: (2016) -
Correction: Mucosal effects for tenofovir 1% gel
por: Hladik, Florian, et al.
Publicado: (2015) -
A randomized safety and pharmacokinetic trial of daily tenofovir 1% gel in term and near-term pregnancy
por: Beigi, Richard H, et al.
Publicado: (2016)